Drug Profile
BIM 23244
Latest Information Update: 04 May 2007
Price :
$50
*
At a glance
- Originator Biomeasure Inc; Institut Federatif Jean Roche
- Class
- Mechanism of Action Somatotropin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Acromegaly
Most Recent Events
- 20 Jan 2003 No development reported - Preclinical for Acromegaly in France (unspecified route)
- 20 Jan 2003 No development reported - Preclinical for Acromegaly in USA (unspecified route)
- 31 Jan 2001 Preclinical development for Acromegaly in France (Unknown route)